Literature DB >> 21035468

Aberrantly silenced promoters retain a persistent memory of the silenced state after long-term reactivation.

Jon A Oyer1, Phillip A Yates, Sarah Godsey, Mitchell S Turker.   

Abstract

A hallmark of aberrant DNA methylation-associated silencing is reversibility. However, long-term stability of reactivated promoters has not been explored. To examine this issue, spontaneous reactivant clones were isolated from mouse embryonal carcinoma cells bearing aberrantly silenced Aprt alleles and re-silencing frequencies were determined as long as three months after reactivation occurred. Despite continuous selection for expression of the reactivated Aprt alleles, exceptionally high spontaneous re-silencing frequencies were observed. A DNA methylation analysis demonstrated retention of sporadic methylation of CpG sites in a protected region of the Aprt promoter in many reactivant alleles suggesting a role for these methylated sites in the re-silencing process. In contrast, a chromatin immunoprecipitation (ChIP) analysis for methyl-H3K4, acetyl-H3K9, and dimethyl-H3K9 levels failed to reveal a specific histone modification that could explain high frequency re-silencing. These results demonstrate that aberrantly silenced and reactivated promoters retain a persistent memory of having undergone the silencing process and suggest the failure to eliminate all CpG methylation as a potential contributing mechanism.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035468      PMCID: PMC3013294          DOI: 10.1016/j.mrfmmm.2010.10.006

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  29 in total

1.  Roles of cell division and gene transcription in the methylation of CpG islands.

Authors:  C M Bender; M L Gonzalgo; F A Gonzales; C T Nguyen; K D Robertson; P A Jones
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 2.  Aberrant methylations in cancer cells: where do they come from?

Authors:  Toshikazu Ushijima; Eriko Okochi-Takada
Journal:  Cancer Sci       Date:  2005-04       Impact factor: 6.716

3.  Molecular analysis of APRT deficiency in mouse P19 teratocarcinoma stem cell line.

Authors:  G E Cooper; D L DiMartino; M S Turker
Journal:  Somat Cell Mol Genet       Date:  1991-03

4.  Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.

Authors:  F V Jacinto; E Ballestar; M Esteller
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

5.  Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation.

Authors:  J R Graff; J G Herman; S Myöhänen; S B Baylin; P M Vertino
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

Review 6.  Alterations in DNA methylation: a fundamental aspect of neoplasia.

Authors:  S B Baylin; J G Herman; J R Graff; P M Vertino; J P Issa
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

7.  The primary function of a redundant Sp1 binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation.

Authors:  P Mummaneni; P Yates; J Simpson; J Rose; M S Turker
Journal:  Nucleic Acids Res       Date:  1998-11-15       Impact factor: 16.971

8.  A cis-acting element accounts for a conserved methylation pattern upstream of the mouse adenine phosphoribosyltransferase gene.

Authors:  P Mummaneni; P L Bishop; M S Turker
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

9.  Epigenetic gene inactivation induced by a cis-acting methylation center.

Authors:  P Mummaneni; K A Walker; P L Bishop; M S Turker
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

10.  Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.

Authors:  M L Veigl; L Kasturi; J Olechnowicz; A H Ma; J D Lutterbaugh; S Periyasamy; G M Li; J Drummond; P L Modrich; W D Sedwick; S D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.